Ingeborg Schafhalter-Zoppoth, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 37 years
- Graduated 1989
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 057003 · 059016 · California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp · Novato Community Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Schafhalter-Zoppoth’s office at (415) 600-1020 to ask if they take your plan before you enroll.
California Medical Board record
Licence A122988 · Current
Licensed to practise in California · since 2012 · expires 2028-01-31 · University of Graz Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Preventive Medicine - Addiction Medicine
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$150,470
Medicare paid this office $150,470 for 465 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 328 | $67,009 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 106 | $16,507 | $156 |
| Short return visit (20+ min) | 178 | $15,457 | $73 |
| Sarscov2 vac 50 mcg/0.5ml im | 83 | $14,723 | $150 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 35 | $10,177 | $291 |
See all 11 services
| Return visit (30+ min) | 328 | $67,009 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 106 | $16,507 | $156 |
| Short return visit (20+ min) | 178 | $15,457 | $73 |
| Sarscov2 vac 50 mcg/0.5ml im | 83 | $14,723 | $150 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 35 | $10,177 | $291 |
| Admn sarscov2 vacc 1 dose | 83 | $5,056 | $52 |
| Influenza vaccine, inactivated | 61 | $4,991 | $82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 131 | $2,609 | $14 |
| Administration of influenza virus vaccine | 67 | $2,592 | $39 |
| Administration of pneumococcal vaccine | 33 | $1,276 | $39 |
| Removal of impacted ear wax | 11 | $459 | $42 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | – | – | – | – | – | 11 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
465 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 14% · Women 65% · Also on Medicaid 27% · Health risk score 1.15. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 66% · Diabetes 23% · Chronic kidney disease 20% · Coronary heart disease 19% · Depression 19% · Atrial fibrillation 16% · Heart failure 13% · Cancer 13% · COPD 11% · Dementia 7% · Stroke 5%.
The office billed $435,189, Medicare allowed $188,603 and paid $150,470; for 1,691 services of 53 kinds; $30,557 of it was for drugs given in the office and $119,913 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 465 | 1,691 | 75 | 1.15 | $435,189 | $150,470 |
| 2023 | 402 | 1,269 | 75 | 1.09 | $338,216 | $125,017 |
| 2022 | 366 | 1,050 | 73 | 1.14 | $263,684 | $92,841 |
| 2021 | 321 | 919 | 73 | 1.19 | $223,823 | $81,463 |
| 2020 | 300 | 733 | 72 | 1.34 | $180,084 | $56,526 |
| 2019 | 249 | 754 | 72 | 1.24 | $191,085 | $56,379 |
| 2018 | 243 | 610 | 72 | 1.19 | $152,454 | $44,097 |
| 2017 | 234 | 761 | 72 | 1.53 | $171,858 | $52,448 |
| 2016 | 235 | 747 | 70 | 1.33 | $171,505 | $53,066 |
| 2015 | 213 | 630 | 70 | 1.39 | $156,374 | $47,899 |
| 2014 | 227 | 659 | 69 | 1.24 | $146,014 | $42,995 |
| 2013 | 97 | 186 | 68 | 1.14 | $42,409 | $13,495 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 282 | $59,022 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 103 | $16,121 | $157 |
| Short return visit (20+ min) | 159 | $14,063 | $76 |
| Sarscov2 vac 50 mcg/0.5ml im | 55 | $7,865 | $143 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 32 | $7,721 | $241 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 64 | $4,911 | $76 |
| Admn sarscov2 vacc 1 dose | 55 | $2,724 | $50 |
| Administration of influenza virus vaccine | 69 | $2,600 | $37 |
| Long return visit (40+ min) | 16 | $2,536 | $158 |
| Administration of pneumococcal vaccine | 35 | $1,300 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $156 | $12 |
2022: 11 services
| Return visit (30+ min) | 277 | $49,567 | $103 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 78 | $12,203 | $156 |
| Short return visit (20+ min) | 132 | $11,325 | $75 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 13 | $3,174 | $244 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 38 | $2,670 | $70 |
| Pneumococcal vaccine, 23-valent | 16 | $2,117 | $132 |
| Administration of influenza virus vaccine | 49 | $1,798 | $37 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 35 | $1,715 | $49 |
| Adm sarscv2 bvl 50mcg/.5ml a | 30 | $1,455 | $49 |
| Administration of pneumococcal vaccine | 29 | $1,070 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $248 | $14 |
2021: 12 services
| Return visit (30+ min) | 228 | $44,062 | $105 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $9,512 | $159 |
| Short return visit (20+ min) | 91 | $8,752 | $80 |
| Influenza vaccine split virus, preservative free | 48 | $3,181 | $65 |
| Pneumococcal vaccine, 23-valent | 24 | $2,992 | $125 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,596 | $200 |
| Long return visit (40+ min) | 12 | $1,813 | $139 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 32 | $1,592 | $50 |
| Administration of influenza virus vaccine | 55 | $1,183 | $21 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $921 | $77 |
| Administration of pneumococcal vaccine | 23 | $487 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $375 | $12 |
2020: 10 services
| Return visit (30+ min) | 216 | $29,419 | $88 |
| Telephone medical discussion with physician, 21-30 minutes | 60 | $7,852 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,163 | $140 |
| Short return visit (20+ min) | 48 | $2,740 | $56 |
| Pneumococcal vaccine, 23-valent | 16 | $1,879 | $117 |
| Influenza vaccine split virus, preservative free | 29 | $1,741 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $810 | $67 |
| Administration of influenza virus vaccine | 36 | $739 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $437 | $15 |
| Administration of pneumococcal vaccine | 18 | $368 | $20 |
2019: 9 services
| Return visit (30+ min) | 196 | $33,900 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $5,585 | $140 |
| Short return visit (20+ min) | 58 | $3,549 | $55 |
| Pneumococcal vaccine, 13-valent | 15 | $3,115 | $208 |
| Influenza vaccine split virus, preservative free | 40 | $2,192 | $53 |
| Pneumococcal vaccine, 23-valent | 19 | $2,114 | $111 |
| Administration of influenza virus vaccine | 45 | $928 | $20 |
| Administration of pneumococcal vaccine | 33 | $666 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $464 | $14 |
2018: 9 services
| Return visit (30+ min) | 173 | $24,838 | $86 |
| Short return visit (20+ min) | 74 | $4,490 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,596 | $138 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $2,413 | $201 |
| Pneumococcal vaccine, 13-valent | 11 | $2,187 | $199 |
| Influenza vaccine split virus, preservative free | 36 | $1,546 | $43 |
| Administration of influenza virus vaccine | 41 | $1,037 | $25 |
| Administration of pneumococcal vaccine | 19 | $481 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $309 | $13 |
2017: 8 services
| Return visit (30+ min) | 156 | $24,705 | $86 |
| Short return visit (20+ min) | 130 | $10,630 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $5,680 | $139 |
| Influenza vaccine split virus, preservative free | 51 | $2,310 | $44 |
| Administration of influenza virus vaccine | 63 | $2,136 | $32 |
| Pneumococcal vaccine, 13-valent | 11 | $2,065 | $188 |
| Administration of pneumococcal vaccine | 20 | $647 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $296 | $16 |
2016: 11 services
| Return visit (30+ min) | 156 | $28,003 | $86 |
| Short return visit (20+ min) | 93 | $6,162 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,148 | $140 |
| Pneumococcal vaccine, 13-valent | 20 | $3,495 | $175 |
| Administration of influenza virus vaccine | 59 | $1,865 | $31 |
| Influenza vaccine split virus, preservative free | 43 | $1,612 | $37 |
| Pneumococcal vaccine, 23-valent | 11 | $962 | $87 |
| Administration of pneumococcal vaccine | 31 | $933 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $251 | $14 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $216 | $18 |
| Urinalysis, manual test | 13 | $48 | $3 |
2015: 8 services
| Return visit (30+ min) | 123 | $22,683 | $91 |
| Short return visit (20+ min) | 107 | $7,612 | $58 |
| Pneumococcal vaccine, 13-valent | 41 | $6,619 | $161 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,932 | $140 |
| Administration of pneumococcal vaccine | 42 | $1,250 | $28 |
| Administration of influenza virus vaccine | 37 | $1,052 | $28 |
| Influenza vaccine split virus, preservative free | 25 | $881 | $35 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $271 | $16 |
2014: 11 services
| Return visit (30+ min) | 136 | $21,593 | $84 |
| Short return visit (20+ min) | 107 | $9,092 | $59 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 21 | $4,206 | $200 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,635 | $136 |
| Administration of influenza virus vaccine | 55 | $1,592 | $28 |
| Pneumococcal vaccine, 23-valent | 13 | $992 | $76 |
| Administration of pneumococcal vaccine | 17 | $483 | $28 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 30 | $354 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $237 | $15 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $211 | $18 |
| Urinalysis, manual test | 13 | $48 | $3 |
2013: 3 services
| Return visit (30+ min) | 57 | $7,313 | $96 |
| Short return visit (20+ min) | 30 | $2,055 | $64 |
| Administration of influenza virus vaccine | 18 | $512 | $28 |
Medicaid work
$10,927 in 2024
Medicaid paid $10,927 for 354 billed services this clinician did in 2024, up to 44 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 296 | $9,579 |
| Short return visit (20+ min) | 58 | $1,348 |
| 2024 | 354 | 2 | 44 | $10,927 |
| 2023 | 572 | 2 | 52 | $12,272 |
| 2022 | 484 | 3 | 50 | $4,361 |
| 2021 | 356 | 4 | 36 | $4,238 |
| 2020 | 296 | 1 | 50 | $3,646 |
| 2019 | 395 | 2 | 40 | $9,592 |
| 2018 | 393 | 3 | 43 | $4,615 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 443 | $10,774 |
| Short return visit (20+ min) | 129 | $1,498 |
2022
| Return visit (30+ min) | 391 | $3,750 |
| Short return visit (20+ min) | 80 | $604 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $8 |
2021
| Return visit (30+ min) | 274 | $3,744 |
| Short return visit (20+ min) | 39 | $372 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $92 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 29 | $30 |
2020
| Return visit (30+ min) | 296 | $3,646 |
2019
| Return visit (30+ min) | 366 | $9,532 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 29 | $59 |
2018
| Return visit (30+ min) | 326 | $4,129 |
| Short return visit (20+ min) | 48 | $442 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 19 | $45 |
Drugs they prescribed that Part D paid
$308,319
Pharmacies billed $308,319 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (98 of 3,592) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 16% of their opioid prescriptions.
3,092 generic and 489 brand-name prescriptions · $308,319 in drug cost · 45 antibiotic prescriptions to 34 people · 20 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 97 | $93,522 | $964 |
| Jardiance | 19 | $27,236 | $1,433 |
| Xarelto | 13 | $10,126 | $779 |
| Atorvastatin | 357 | $3,849 | $11 |
| Buprenorphine | 13 | $3,627 | $279 |
See all 69 drugs
| Eliquis | 97 | $93,522 | $964 |
| Jardiance | 19 | $27,236 | $1,433 |
| Xarelto | 13 | $10,126 | $779 |
| Atorvastatin | 357 | $3,849 | $11 |
| Buprenorphine | 13 | $3,627 | $279 |
| Wixela Inhub | 13 | $2,738 | $211 |
| Amlodipine Besylate | 277 | $2,342 | $8 |
| Levothyroxine | 137 | $2,097 | $15 |
| Losartan | 177 | $2,090 | $12 |
| Rosuvastatin | 64 | $1,661 | $26 |
| Synthroid | 16 | $1,620 | $101 |
| Diclofenac | 21 | $1,341 | $64 |
| Alendronate | 109 | $1,285 | $12 |
| Albuterol Sulfate Hfa | 40 | $1,148 | $29 |
| Estradiol | 19 | $1,099 | $58 |
| Gabapentin | 57 | $1,083 | $19 |
| Pantoprazole | 61 | $1,057 | $17 |
| Fluticasone Propionate | 48 | $991 | $21 |
| Metoprolol | 58 | $953 | $16 |
| Lisinopril | 118 | $913 | $8 |
| Pravastatin | 36 | $893 | $25 |
| Tamsulosin | 60 | $847 | $14 |
| Lidocaine | 15 | $845 | $56 |
| Mirtazapine | 36 | $820 | $23 |
| Baclofen | 28 | $789 | $28 |
| Hydrocodone-Acetaminophen | 35 | $710 | $20 |
| Bupropion Xl | 29 | $665 | $23 |
| Omeprazole | 35 | $651 | $19 |
| Trazodone | 55 | $630 | $11 |
| Escitalopram | 47 | $616 | $13 |
| Valsartan | 25 | $565 | $23 |
| Amlodipine-Valsartan | 11 | $535 | $49 |
| Metformin Hcl Er | 44 | $486 | $11 |
| Nifedipine Er | 15 | $442 | $29 |
| Metformin | 43 | $410 | $10 |
| Carvedilol | 40 | $402 | $10 |
| Losartan-Hydrochlorothiazide | 26 | $392 | $15 |
| Olmesartan Medoxomil | 17 | $370 | $22 |
| Oxycodone | 24 | $346 | $14 |
| Sertraline | 32 | $337 | $11 |
| Diltiazem 24hr Er (Cd) | 11 | $331 | $30 |
| Montelukast | 19 | $331 | $17 |
| Finasteride | 22 | $305 | $14 |
| Furosemide | 51 | $296 | $6 |
| Duloxetine | 16 | $243 | $15 |
| Potassium Citrate Er | 12 | $237 | $20 |
| Valacyclovir | 15 | $233 | $16 |
| Famotidine | 23 | $205 | $9 |
| Allopurinol | 21 | $197 | $9 |
| Hydrochlorothiazide | 38 | $175 | $5 |
| Tramadol | 15 | $166 | $11 |
| Potassium Chloride | 15 | $164 | $11 |
| Triamcinolone Acetonide | 29 | $163 | $6 |
| Pregabalin | 15 | $152 | $10 |
| Bupropion Hcl Sr | 12 | $146 | $12 |
| Spironolactone | 17 | $134 | $8 |
| Nitrofurantoin Mono-Macro | 12 | $130 | $11 |
| Simvastatin | 38 | $130 | $3 |
| Clopidogrel | 18 | $105 | $6 |
| Atenolol | 18 | $100 | $6 |
| Zolpidem | 24 | $89 | $4 |
| Isosorbide Mononitrate Er | 16 | $89 | $6 |
| Hydrocortisone | 11 | $82 | $7 |
| Meloxicam | 14 | $60 | $4 |
| Citalopram Hbr | 11 | $50 | $5 |
| Olanzapine | 12 | $49 | $4 |
| Metoprolol | 14 | $42 | $3 |
| Diazepam | 15 | $25 | $2 |
| Buspirone | 13 | $8 | $1 |
Year by year
| 2024 | 3,592 | 467 | 3% (98) | 14% | $308,319 |
| 2023 | 3,371 | 429 | 4% (125) | 14% | $373,355 |
| 2022 | 3,412 | 406 | 4% (133) | 15% | $416,468 |
| 2021 | 3,143 | 361 | 3% (90) | None | $384,944 |
| 2020 | 3,089 | 341 | 4% (108) | 16% | $320,723 |
| 2019 | 2,806 | 334 | 3% (85) | None | $248,610 |
| 2018 | 2,155 | 290 | 4% (87) | None | $165,998 |
| 2017 | 2,358 | 295 | 5% (106) | 18% | $198,880 |
| 2016 | 2,012 | 266 | 6% (111) | 17% | $184,038 |
| 2015 | 1,804 | 250 | 7% (129) | None | $168,952 |
| 2014 | 1,309 | 211 | 6% (78) | None | $92,854 |
| 2013 | 298 | 94 | 9% (27) | None | $19,504 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 68 drugs
| Eliquis | 70 | $70,812 | $1,012 |
| Ozempic | 28 | $30,236 | $1,080 |
| Jardiance | 15 | $17,978 | $1,199 |
| Symbicort | 29 | $16,594 | $572 |
| Atorvastatin | 289 | $4,896 | $17 |
| Basaglar Kwikpen U-100 | 12 | $4,125 | $344 |
| Amlodipine Besylate | 219 | $3,493 | $16 |
| Losartan | 148 | $2,555 | $17 |
| Mirtazapine | 77 | $2,408 | $31 |
| Tamsulosin | 66 | $2,354 | $36 |
| Gabapentin | 65 | $2,260 | $35 |
| Levothyroxine | 107 | $2,245 | $21 |
| Diclofenac | 34 | $2,178 | $64 |
| Hydrocodone-Acetaminophen | 82 | $1,998 | $24 |
| Albuterol Sulfate Hfa | 48 | $1,953 | $41 |
| Pantoprazole | 57 | $1,804 | $32 |
| Clobetasol Propionate | 13 | $1,743 | $134 |
| Rosuvastatin | 62 | $1,668 | $27 |
| Alendronate | 88 | $1,534 | $17 |
| Fluticasone Propionate | 45 | $1,479 | $33 |
| Metoprolol | 59 | $1,383 | $23 |
| Synthroid | 12 | $1,281 | $107 |
| Lisinopril | 104 | $1,266 | $12 |
| Escitalopram | 31 | $1,237 | $40 |
| Metformin | 55 | $1,177 | $21 |
| Trazodone | 48 | $1,153 | $24 |
| Azelastine | 13 | $1,117 | $86 |
| Pregabalin | 20 | $1,092 | $55 |
| Omeprazole | 41 | $1,035 | $25 |
| Metformin Hcl Er | 29 | $948 | $33 |
| Bupropion Xl | 29 | $908 | $31 |
| Carvedilol | 44 | $853 | $19 |
| Celecoxib | 17 | $831 | $49 |
| Diltiazem 24hr Er (Cd) | 13 | $824 | $63 |
| Nifedipine Er | 11 | $761 | $69 |
| Simvastatin | 31 | $750 | $24 |
| Montelukast | 20 | $719 | $36 |
| Ventolin Hfa | 12 | $713 | $59 |
| Duloxetine | 25 | $612 | $24 |
| Pravastatin | 30 | $611 | $20 |
| Potassium Chloride | 12 | $570 | $47 |
| Tizanidine | 16 | $564 | $35 |
| Losartan-Hydrochlorothiazide | 22 | $561 | $25 |
| Sertraline | 25 | $519 | $21 |
| Bupropion Hcl Sr | 12 | $503 | $42 |
| Furosemide | 65 | $475 | $7 |
| Clopidogrel | 18 | $328 | $18 |
| Isosorbide Mononitrate Er | 11 | $318 | $29 |
| Famotidine | 23 | $300 | $13 |
| Finasteride | 17 | $298 | $18 |
| Allopurinol | 20 | $272 | $14 |
| Triamcinolone Acetonide | 24 | $265 | $11 |
| Nitrofurantoin Mono-Macro | 16 | $253 | $16 |
| Benazepril | 12 | $241 | $20 |
| Hydrochlorothiazide | 44 | $217 | $5 |
| Atenolol | 17 | $217 | $13 |
| Pioglitazone | 11 | $209 | $19 |
| Meloxicam | 24 | $198 | $8 |
| Paroxetine | 11 | $182 | $17 |
| Paxlovid (Eua) | 16 | $168 | $11 |
| Baclofen | 14 | $159 | $11 |
| Lisinopril-Hydrochlorothiazide | 13 | $158 | $12 |
| Valacyclovir | 12 | $150 | $13 |
| Tramadol | 13 | $133 | $10 |
| Metoprolol | 14 | $126 | $9 |
| Hydrocortisone | 14 | $107 | $8 |
| Zolpidem | 15 | $56 | $4 |
| Diazepam | 15 | $26 | $2 |
2022: 76 drugs
| Biktarvy | 13 | $51,714 | $3,978 |
| Eliquis | 60 | $49,964 | $833 |
| Spiriva Handihaler | 13 | $20,533 | $1,579 |
| Symbicort | 27 | $16,570 | $614 |
| Jardiance | 21 | $15,114 | $720 |
| Entresto | 12 | $14,970 | $1,248 |
| Xarelto | 11 | $13,675 | $1,243 |
| Incruse Ellipta | 25 | $11,053 | $442 |
| Anoro Ellipta | 14 | $6,725 | $480 |
| Clobetasol Propionate | 21 | $4,882 | $232 |
| Atorvastatin | 287 | $4,317 | $15 |
| Losartan | 146 | $3,073 | $21 |
| Albuterol Sulfate Hfa | 47 | $2,936 | $62 |
| Clocortolone Pivalate | 12 | $2,919 | $243 |
| Belbuca | 17 | $2,840 | $167 |
| Hydrocodone-Acetaminophen | 79 | $2,623 | $33 |
| Amlodipine Besylate | 206 | $2,453 | $12 |
| Levothyroxine | 102 | $2,211 | $22 |
| Buprenorphine-Naloxone | 18 | $2,211 | $123 |
| Mirtazapine | 53 | $1,979 | $37 |
| Gabapentin | 47 | $1,838 | $39 |
| Diclofenac | 34 | $1,702 | $50 |
| Tamsulosin | 58 | $1,624 | $28 |
| Lisinopril | 136 | $1,405 | $10 |
| Rosuvastatin | 40 | $1,355 | $34 |
| Metoprolol | 63 | $1,312 | $21 |
| Pantoprazole | 56 | $1,232 | $22 |
| Pregabalin | 15 | $1,183 | $79 |
| Diltiazem 24hr Er (Cd) | 14 | $1,028 | $73 |
| Alendronate | 65 | $998 | $15 |
| Simvastatin | 49 | $967 | $20 |
| Fluticasone Propionate | 41 | $958 | $23 |
| Celecoxib | 15 | $906 | $60 |
| Metformin Hcl Er | 37 | $886 | $24 |
| Metformin | 52 | $846 | $16 |
| Valacyclovir | 13 | $795 | $61 |
| Bupropion Xl | 21 | $758 | $36 |
| Furosemide | 51 | $673 | $13 |
| Pravastatin | 30 | $640 | $21 |
| Carvedilol | 39 | $627 | $16 |
| Omeprazole | 39 | $626 | $16 |
| Trazodone | 31 | $615 | $20 |
| Tizanidine | 16 | $614 | $38 |
| Bumetanide | 11 | $586 | $53 |
| Amlodipine Besylate-Benazepril | 11 | $551 | $50 |
| Losartan-Hydrochlorothiazide | 22 | $550 | $25 |
| Escitalopram | 33 | $521 | $16 |
| Montelukast | 19 | $493 | $26 |
| Sertraline | 24 | $493 | $21 |
| Potassium Chloride | 12 | $466 | $39 |
| Oxycodone-Acetaminophen | 11 | $404 | $37 |
| Finasteride | 14 | $365 | $26 |
| Duloxetine | 13 | $357 | $27 |
| Bupropion Hcl Sr | 19 | $347 | $18 |
| Baclofen | 20 | $327 | $16 |
| Chlorthalidone | 11 | $299 | $27 |
| Allopurinol | 18 | $294 | $16 |
| Clopidogrel | 17 | $294 | $17 |
| Benazepril | 17 | $284 | $17 |
| Hydrochlorothiazide | 45 | $281 | $6 |
| Hydralazine | 25 | $280 | $11 |
| Paroxetine | 12 | $280 | $23 |
| Isosorbide Mononitrate Er | 11 | $270 | $25 |
| Meloxicam | 35 | $256 | $7 |
| Famotidine | 28 | $243 | $9 |
| Glipizide | 12 | $202 | $17 |
| Triamterene-Hydrochlorothiazid | 11 | $195 | $18 |
| Triamcinolone Acetonide | 23 | $194 | $8 |
| Paxlovid (Eua) | 17 | $177 | $10 |
| Atenolol | 13 | $148 | $11 |
| Hydrocortisone | 16 | $141 | $9 |
| Nitrofurantoin Mono-Macro | 11 | $112 | $10 |
| Ibuprofen | 16 | $74 | $5 |
| Citalopram Hbr | 11 | $72 | $7 |
| Tramadol | 12 | $60 | $5 |
| Sulfamethoxazole-Trimethoprim | 18 | $50 | $3 |
2021: 74 drugs
| Humira | 13 | $78,207 | $6,016 |
| Eliquis | 98 | $71,332 | $728 |
| Symbicort | 33 | $23,151 | $702 |
| Spiriva | 11 | $14,189 | $1,290 |
| Novolog Flexpen | 18 | $10,627 | $590 |
| Incruse Ellipta | 25 | $10,488 | $420 |
| Lantus | 16 | $7,205 | $450 |
| Clobetasol Propionate | 27 | $6,749 | $250 |
| Lantus Solostar | 11 | $5,442 | $495 |
| Atorvastatin | 290 | $4,639 | $16 |
| Calcipotriene | 12 | $3,830 | $319 |
| Albuterol Sulfate Hfa | 59 | $3,087 | $52 |
| Levothyroxine | 100 | $2,345 | $23 |
| Metronidazole | 18 | $2,087 | $116 |
| Losartan | 132 | $1,983 | $15 |
| Amlodipine Besylate | 170 | $1,901 | $11 |
| Diclofenac | 36 | $1,662 | $46 |
| Rosuvastatin | 33 | $1,600 | $48 |
| Metoprolol | 66 | $1,590 | $24 |
| Tamsulosin | 62 | $1,565 | $25 |
| Gabapentin | 45 | $1,492 | $33 |
| Diltiazem 24hr Er (Cd) | 11 | $1,295 | $118 |
| Pregabalin | 18 | $1,235 | $69 |
| Carvedilol | 65 | $897 | $14 |
| Lisinopril | 107 | $868 | $8 |
| Bupropion Xl | 25 | $830 | $33 |
| Baclofen | 19 | $814 | $43 |
| Alendronate | 69 | $810 | $12 |
| Mirtazapine | 21 | $810 | $39 |
| Omeprazole | 43 | $789 | $18 |
| Hydrocodone-Acetaminophen | 39 | $770 | $20 |
| Quetiapine | 14 | $757 | $54 |
| Pantoprazole | 38 | $747 | $20 |
| Metformin | 60 | $699 | $12 |
| Amlodipine Besylate-Benazepril | 12 | $614 | $51 |
| Montelukast | 13 | $603 | $46 |
| Simvastatin | 62 | $583 | $9 |
| Oxycodone-Acetaminophen | 15 | $536 | $36 |
| Fluticasone Propionate | 27 | $533 | $20 |
| Sertraline | 24 | $525 | $22 |
| Losartan-Hydrochlorothiazide | 16 | $505 | $32 |
| Trazodone | 23 | $500 | $22 |
| Allopurinol | 22 | $494 | $22 |
| Potassium Chloride | 19 | $463 | $24 |
| Metformin Hcl Er | 30 | $459 | $15 |
| Clopidogrel | 25 | $455 | $18 |
| Fludrocortisone Acetate | 15 | $452 | $30 |
| Isosorbide Mononitrate Er | 18 | $450 | $25 |
| Buprenorphine-Naloxone | 12 | $427 | $36 |
| Pravastatin | 17 | $414 | $24 |
| Furosemide | 46 | $353 | $8 |
| Clotrimazole | 16 | $351 | $22 |
| Famotidine | 24 | $291 | $12 |
| Hydrochlorothiazide | 38 | $283 | $7 |
| Doxazosin Mesylate | 11 | $272 | $25 |
| Paroxetine | 11 | $261 | $24 |
| Triamcinolone Acetonide | 26 | $255 | $10 |
| Escitalopram | 14 | $238 | $17 |
| Tizanidine | 12 | $221 | $18 |
| Benazepril | 13 | $200 | $15 |
| Oxycodone | 11 | $184 | $17 |
| Hydroxyzine | 13 | $178 | $14 |
| Hydralazine | 12 | $175 | $15 |
| Naproxen | 12 | $149 | $12 |
| Donepezil | 15 | $149 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $149 | $14 |
| Fluoxetine | 22 | $143 | $7 |
| Atenolol | 14 | $138 | $10 |
| Sumatriptan | 12 | $112 | $9 |
| Hydrocortisone | 11 | $107 | $10 |
| Tramadol | 21 | $87 | $4 |
| Ibuprofen | 12 | $70 | $6 |
| Zolpidem | 14 | $52 | $4 |
| Sulfamethoxazole-Trimethoprim | 14 | $31 | $2 |
2020: 70 drugs
| Eliquis | 68 | $51,911 | $763 |
| Symbicort | 35 | $22,524 | $644 |
| Novolog Flexpen | 24 | $13,885 | $579 |
| Xarelto | 16 | $10,875 | $680 |
| Clobetasol Propionate | 29 | $6,716 | $232 |
| Atorvastatin | 274 | $5,896 | $22 |
| Diltiazem 24hr Er (Cd) | 16 | $3,660 | $229 |
| Colchicine | 18 | $2,735 | $152 |
| Levothyroxine | 82 | $2,115 | $26 |
| Diclofenac | 36 | $2,103 | $58 |
| Albuterol Sulfate Hfa | 35 | $2,067 | $59 |
| Losartan | 129 | $1,876 | $15 |
| Buprenorphine-Naloxone | 12 | $1,730 | $144 |
| Amlodipine Besylate | 186 | $1,722 | $9 |
| Mirtazapine | 41 | $1,554 | $38 |
| Ventolin Hfa | 18 | $1,501 | $83 |
| Metoprolol | 60 | $1,482 | $25 |
| Metronidazole | 14 | $1,449 | $104 |
| Bupropion Xl | 29 | $1,176 | $41 |
| Azelastine | 14 | $1,157 | $83 |
| Rosuvastatin | 15 | $1,155 | $77 |
| Tamsulosin | 58 | $1,028 | $18 |
| Esomeprazole Magnesium | 15 | $1,012 | $67 |
| Potassium Chloride | 40 | $972 | $24 |
| Pregabalin | 12 | $965 | $80 |
| Pantoprazole | 39 | $910 | $23 |
| Omeprazole | 41 | $851 | $21 |
| Lisinopril | 89 | $665 | $7 |
| Trazodone | 43 | $640 | $15 |
| Fluticasone Propionate | 20 | $639 | $32 |
| Carvedilol | 51 | $637 | $12 |
| Metformin | 58 | $578 | $10 |
| Oxybutynin Chloride Er | 13 | $536 | $41 |
| Pravastatin | 15 | $536 | $36 |
| Gabapentin | 29 | $511 | $18 |
| Clopidogrel | 33 | $476 | $14 |
| Hydrocodone-Acetaminophen | 38 | $457 | $12 |
| Hydralazine | 13 | $440 | $34 |
| Allopurinol | 23 | $430 | $19 |
| Alendronate | 40 | $424 | $11 |
| Furosemide | 54 | $420 | $8 |
| Oxycodone-Acetaminophen | 16 | $403 | $25 |
| Simvastatin | 53 | $397 | $7 |
| Buspirone | 11 | $372 | $34 |
| Famotidine | 25 | $372 | $15 |
| Hydrochlorothiazide | 56 | $347 | $6 |
| Doxazosin Mesylate | 12 | $339 | $28 |
| Mometasone Furoate | 11 | $335 | $30 |
| Finasteride | 17 | $322 | $19 |
| Benazepril | 20 | $273 | $14 |
| Chlorthalidone | 11 | $272 | $25 |
| Metformin Hcl Er | 19 | $268 | $14 |
| Sertraline | 23 | $268 | $12 |
| Baclofen | 13 | $264 | $20 |
| Oxycodone | 16 | $238 | $15 |
| Sumatriptan | 11 | $226 | $21 |
| Prednisone | 13 | $217 | $17 |
| Ondansetron | 11 | $210 | $19 |
| Escitalopram | 15 | $207 | $14 |
| Ketoconazole | 12 | $178 | $15 |
| Lisinopril-Hydrochlorothiazide | 11 | $162 | $15 |
| Fluoxetine | 22 | $155 | $7 |
| Triamcinolone Acetonide | 22 | $131 | $6 |
| Paroxetine | 12 | $123 | $10 |
| Citalopram Hbr | 24 | $122 | $5 |
| Ibuprofen | 11 | $120 | $11 |
| Tramadol | 24 | $106 | $4 |
| Metoprolol | 14 | $77 | $6 |
| Zolpidem | 12 | $49 | $4 |
| Clonazepam | 12 | $25 | $2 |
2019: 67 drugs
| Eliquis | None | 70 | $38,431 | $549 |
| Xarelto | None | 30 | $15,550 | $518 |
| Novolog Flexpen | None | 24 | $13,564 | $565 |
| Symbicort | None | 16 | $12,608 | $788 |
| Januvia | None | 12 | $12,103 | $1,009 |
| Lyrica | None | 16 | $10,811 | $676 |
| Premarin | None | 16 | $6,583 | $411 |
| Atorvastatin | None | 237 | $5,880 | $25 |
| Estring | None | 12 | $5,589 | $466 |
| Rytary | Parkinson's | 12 | $4,769 | $397 |
| Clobetasol Propionate | None | 19 | $4,557 | $240 |
| Levothyroxine | None | 84 | $2,044 | $24 |
| Ventolin Hfa | None | 28 | $1,736 | $62 |
| Amlodipine Besylate | None | 181 | $1,629 | $9 |
| Azelastine | None | 15 | $1,596 | $106 |
| Losartan | None | 138 | $1,559 | $11 |
| Tamsulosin | None | 48 | $1,488 | $31 |
| Potassium Chloride | None | 32 | $1,443 | $45 |
| Diclofenac | None | 23 | $1,416 | $62 |
| Mirtazapine | None | 25 | $1,395 | $56 |
| Metoprolol | None | 41 | $1,228 | $30 |
| Potassium Citrate Er | None | 11 | $1,218 | $111 |
| Omeprazole | None | 32 | $990 | $31 |
| Fluticasone Propionate | None | 33 | $949 | $29 |
| Bupropion Xl | None | 30 | $858 | $29 |
| Buspirone | None | 12 | $775 | $65 |
| Pravastatin | None | 17 | $621 | $37 |
| Lisinopril | None | 88 | $613 | $7 |
| Gabapentin | None | 43 | $578 | $13 |
| Doxazosin Mesylate | None | 17 | $518 | $30 |
| Trazodone | None | 42 | $500 | $12 |
| Simvastatin | None | 47 | $499 | $11 |
| Carvedilol | None | 44 | $491 | $11 |
| Finasteride | None | 24 | $479 | $20 |
| Probenecid | None | 13 | $447 | $34 |
| Benazepril | None | 23 | $418 | $18 |
| Chlorthalidone | None | 11 | $405 | $37 |
| Oxycodone-Acetaminophen | None | 20 | $403 | $20 |
| Pantoprazole | None | 40 | $399 | $10 |
| Sertraline | None | 27 | $396 | $15 |
| Metformin | None | 51 | $368 | $7 |
| Furosemide | None | 59 | $363 | $6 |
| Alendronate | None | 23 | $358 | $16 |
| Venlafaxine Hcl Er | None | 12 | $299 | $25 |
| Nitrofurantoin Mono-Macro | None | 19 | $298 | $16 |
| Lovastatin | None | 13 | $278 | $21 |
| Montelukast | None | 11 | $261 | $24 |
| Ketoconazole | None | 14 | $255 | $18 |
| Ranitidine | None | 12 | $250 | $21 |
| Allopurinol | None | 20 | $247 | $12 |
| Tramadol | None | 30 | $240 | $8 |
| Valsartan | None | 12 | $236 | $20 |
| Hydrocodone-Acetaminophen | None | 14 | $232 | $17 |
| Sumatriptan | None | 16 | $215 | $13 |
| Naproxen | None | 11 | $209 | $19 |
| Clopidogrel | None | 19 | $199 | $10 |
| Hydrochlorothiazide | None | 34 | $177 | $5 |
| Hydrocortisone | None | 13 | $160 | $12 |
| Famotidine | None | 16 | $155 | $10 |
| Citalopram Hbr | None | 23 | $148 | $6 |
| Spironolactone | None | 13 | $139 | $11 |
| Ibuprofen | None | 13 | $123 | $9 |
| Amitriptyline | None | 11 | $111 | $10 |
| Metoprolol | None | 19 | $79 | $4 |
| Triamcinolone Acetonide | None | 13 | $71 | $5 |
| Escitalopram | None | 12 | $64 | $5 |
| Clonazepam | None | 18 | $33 | $2 |
2018: 53 drugs
| Spiriva | 23 | $17,462 | $759 |
| Xarelto | 23 | $14,332 | $623 |
| Symbicort | 17 | $10,159 | $598 |
| Lyrica | 11 | $9,531 | $866 |
| Eliquis | 17 | $8,882 | $522 |
| Atorvastatin | 178 | $4,550 | $26 |
| Ventolin Hfa | 38 | $2,364 | $62 |
| Metoprolol | 40 | $2,305 | $58 |
| Levothyroxine | 55 | $1,464 | $27 |
| Potassium Chloride | 20 | $1,270 | $63 |
| Tamsulosin | 41 | $1,222 | $30 |
| Azelastine | 13 | $1,102 | $85 |
| Losartan | 128 | $1,012 | $8 |
| Amlodipine Besylate | 162 | $972 | $6 |
| Mirtazapine | 20 | $824 | $41 |
| Buspirone | 12 | $817 | $68 |
| Finasteride | 19 | $760 | $40 |
| Gabapentin | 35 | $755 | $22 |
| Proair Hfa | 11 | $700 | $64 |
| Bupropion Xl | 20 | $640 | $32 |
| Fluticasone Propionate | 28 | $548 | $20 |
| Valsartan | 16 | $541 | $34 |
| Montelukast | 20 | $521 | $26 |
| Oxycodone-Acetaminophen | 17 | $456 | $27 |
| Omeprazole | 28 | $412 | $15 |
| Lisinopril | 68 | $403 | $6 |
| Felodipine Er | 13 | $395 | $30 |
| Metformin | 47 | $382 | $8 |
| Carvedilol | 34 | $363 | $11 |
| Pantoprazole | 33 | $320 | $10 |
| Trazodone | 32 | $319 | $10 |
| Sumatriptan | 19 | $318 | $17 |
| Lovastatin | 15 | $316 | $21 |
| Nystop | 11 | $311 | $28 |
| Amlodipine Besylate-Benazepril | 16 | $281 | $18 |
| Furosemide | 51 | $267 | $5 |
| Simvastatin | 46 | $257 | $6 |
| Benazepril | 15 | $250 | $17 |
| Tramadol | 36 | $241 | $7 |
| Alendronate | 18 | $220 | $12 |
| Losartan-Hydrochlorothiazide | 11 | $218 | $20 |
| Oxycodone | 11 | $198 | $18 |
| Naproxen | 23 | $195 | $8 |
| Hydrochlorothiazide | 37 | $189 | $5 |
| Metformin Hcl Er | 18 | $187 | $10 |
| Fluoxetine | 13 | $143 | $11 |
| Clopidogrel | 13 | $102 | $8 |
| Donepezil | 11 | $91 | $8 |
| Citalopram Hbr | 23 | $81 | $4 |
| Atenolol | 18 | $71 | $4 |
| Triamcinolone Acetonide | 11 | $59 | $5 |
| Metoprolol | 11 | $54 | $5 |
| Clonazepam | 19 | $35 | $2 |
2017: 56 drugs
| Novolog Flexpen | 25 | $19,916 | $797 |
| Spiriva | 22 | $14,671 | $667 |
| Eliquis | 27 | $14,513 | $538 |
| Symbicort | 18 | $10,927 | $607 |
| Lyrica | 12 | $9,363 | $780 |
| Xarelto | 16 | $9,102 | $569 |
| Advair Diskus | 11 | $8,473 | $770 |
| Toujeo Solostar | 12 | $4,181 | $348 |
| Atorvastatin | 171 | $3,624 | $21 |
| Lantus Solostar | 11 | $2,954 | $269 |
| Metoprolol | 40 | $2,253 | $56 |
| Ventolin Hfa | 35 | $2,242 | $64 |
| Mirtazapine | 26 | $1,203 | $46 |
| Levothyroxine | 41 | $1,086 | $26 |
| Proair Hfa | 13 | $973 | $75 |
| Potassium Chloride | 39 | $967 | $25 |
| Gabapentin | 33 | $947 | $29 |
| Metformin Hcl Er | 17 | $898 | $53 |
| Fluticasone Propionate | 42 | $826 | $20 |
| Buspirone | 14 | $764 | $55 |
| Omeprazole | 63 | $704 | $11 |
| Amlodipine Besylate | 143 | $676 | $5 |
| Losartan | 89 | $652 | $7 |
| Hydrocodone-Acetaminophen | 29 | $548 | $19 |
| Finasteride | 16 | $477 | $30 |
| Diclofenac | 16 | $462 | $29 |
| Bupropion Xl | 20 | $455 | $23 |
| Tamsulosin | 21 | $453 | $22 |
| Metformin | 53 | $364 | $7 |
| Chlorthalidone | 12 | $354 | $30 |
| Lisinopril | 72 | $354 | $5 |
| Carvedilol | 34 | $320 | $9 |
| Oxycodone-Acetaminophen | 25 | $282 | $11 |
| Trazodone | 34 | $280 | $8 |
| Simvastatin | 43 | $265 | $6 |
| Alendronate | 16 | $253 | $16 |
| Pantoprazole | 20 | $244 | $12 |
| Furosemide | 67 | $234 | $3 |
| Clopidogrel | 30 | $192 | $6 |
| Hydrochlorothiazide | 46 | $187 | $4 |
| Sumatriptan | 15 | $176 | $12 |
| Ssd | 15 | $175 | $12 |
| Glipizide Er | 13 | $168 | $13 |
| Metoprolol | 27 | $166 | $6 |
| Naproxen | 25 | $158 | $6 |
| Sertraline | 27 | $153 | $6 |
| Escitalopram | 12 | $123 | $10 |
| Benazepril | 13 | $107 | $8 |
| Triamcinolone Acetonide | 18 | $102 | $6 |
| Lovastatin | 11 | $82 | $7 |
| Clonazepam | 27 | $68 | $3 |
| Tramadol | 25 | $61 | $2 |
| Atenolol | 16 | $60 | $4 |
| Donepezil | 11 | $60 | $5 |
| Fluoxetine | 13 | $45 | $3 |
| Citalopram Hbr | 14 | $45 | $3 |
2016: 48 drugs
| Renvela | 13 | $19,910 | $1,532 |
| Spiriva | 23 | $16,691 | $726 |
| Symbicort | 21 | $13,052 | $622 |
| Novolog Flexpen | 15 | $10,342 | $689 |
| Aripiprazole | 13 | $6,886 | $530 |
| Atorvastatin | 114 | $2,389 | $21 |
| Proair Hfa | 35 | $2,098 | $60 |
| Mirtazapine | 35 | $1,615 | $46 |
| Metoprolol | 39 | $1,469 | $38 |
| Levothyroxine | 49 | $1,116 | $23 |
| Ventolin Hfa | 17 | $1,096 | $64 |
| Hydrocodone-Acetaminophen | 48 | $1,013 | $21 |
| Fluticasone Propionate | 44 | $982 | $22 |
| Amlodipine Besylate | 131 | $976 | $7 |
| Gabapentin | 37 | $840 | $23 |
| Losartan | 85 | $824 | $10 |
| Valsartan | 12 | $750 | $62 |
| Fluoxetine | 24 | $498 | $21 |
| Omeprazole | 46 | $448 | $10 |
| Lisinopril | 68 | $404 | $6 |
| Potassium Chloride | 17 | $358 | $21 |
| Trazodone | 15 | $319 | $21 |
| Furosemide | 68 | $290 | $4 |
| Tamsulosin | 11 | $287 | $26 |
| Simvastatin | 37 | $284 | $8 |
| Clopidogrel | 31 | $266 | $9 |
| Zolpidem | 20 | $241 | $12 |
| Pantoprazole | 25 | $232 | $9 |
| Naproxen | 25 | $223 | $9 |
| Lovastatin | 14 | $218 | $16 |
| Metformin | 35 | $209 | $6 |
| Glipizide Er | 20 | $183 | $9 |
| Finasteride | 11 | $181 | $16 |
| Sumatriptan | 13 | $172 | $13 |
| Carvedilol | 30 | $171 | $6 |
| Metoprolol | 22 | $166 | $8 |
| Oxycodone | 12 | $163 | $14 |
| Sertraline | 12 | $146 | $12 |
| Oxycodone-Acetaminophen | 12 | $122 | $10 |
| Citalopram Hbr | 17 | $118 | $7 |
| Diazepam | 14 | $118 | $8 |
| Triamcinolone Acetonide | 12 | $112 | $9 |
| Prednisone | 21 | $102 | $5 |
| Tramadol | 16 | $100 | $6 |
| Bupropion Xl | 11 | $90 | $8 |
| Atenolol | 14 | $86 | $6 |
| Ibuprofen | 14 | $80 | $6 |
| Hydrochlorothiazide | 12 | $53 | $4 |
2015: 41 drugs
| Spiriva | 16 | $10,436 | $652 |
| Symbicort | 17 | $9,094 | $535 |
| Januvia | 11 | $8,269 | $752 |
| Proair Hfa | 45 | $3,046 | $68 |
| Gabapentin | 70 | $1,875 | $27 |
| Atorvastatin | 74 | $1,740 | $24 |
| Mirtazapine | 58 | $1,668 | $29 |
| Metoprolol | 27 | $1,529 | $57 |
| Levothyroxine | 42 | $1,087 | $26 |
| Amlodipine Besylate | 122 | $1,050 | $9 |
| Hydrocodone-Acetaminophen | 55 | $869 | $16 |
| Valsartan | 12 | $861 | $72 |
| Losartan | 49 | $617 | $13 |
| Fluticasone Propionate | 33 | $583 | $18 |
| Lisinopril | 83 | $571 | $7 |
| Zolpidem | 39 | $533 | $14 |
| Potassium Chloride | 29 | $523 | $18 |
| Ranitidine | 11 | $425 | $39 |
| Omeprazole | 37 | $390 | $11 |
| Fluoxetine | 17 | $351 | $21 |
| Metformin | 35 | $328 | $9 |
| Clopidogrel | 34 | $313 | $9 |
| Allopurinol | 22 | $308 | $14 |
| Simvastatin | 30 | $285 | $10 |
| Lovastatin | 16 | $240 | $15 |
| Glipizide Er | 14 | $236 | $17 |
| Naproxen | 28 | $230 | $8 |
| Oxycodone | 16 | $213 | $13 |
| Carvedilol | 22 | $207 | $9 |
| Donepezil | 13 | $187 | $14 |
| Furosemide | 30 | $183 | $6 |
| Hydrochlorothiazide | 25 | $179 | $7 |
| Sertraline | 21 | $173 | $8 |
| Triamcinolone Acetonide | 14 | $149 | $11 |
| Tramadol | 13 | $145 | $11 |
| Metoprolol | 25 | $129 | $5 |
| Escitalopram | 11 | $114 | $10 |
| Trazodone | 14 | $96 | $7 |
| Glipizide | 11 | $77 | $7 |
| Alendronate | 12 | $73 | $6 |
| Lorazepam | 12 | $33 | $3 |
2014: 35 drugs
| Spiriva | 16 | $8,445 | $528 |
| Lidoderm | 15 | $4,908 | $327 |
| Symbicort | 13 | $3,751 | $289 |
| Proair Hfa | 29 | $1,978 | $68 |
| Atorvastatin | 53 | $1,544 | $29 |
| Gabapentin | 29 | $886 | $31 |
| Metoprolol | 13 | $807 | $62 |
| Clopidogrel | 19 | $732 | $39 |
| Fluticasone Propionate | 32 | $716 | $22 |
| Amlodipine Besylate | 74 | $674 | $9 |
| Levothyroxine | 30 | $658 | $22 |
| Omeprazole | 41 | $619 | $15 |
| Pravastatin | 22 | $583 | $26 |
| Mirtazapine | 27 | $557 | $21 |
| Potassium Chloride | 16 | $532 | $33 |
| Hydrocodone-Acetaminophen | 43 | $519 | $12 |
| Lisinopril | 56 | $483 | $9 |
| Metformin | 47 | $429 | $9 |
| Simvastatin | 26 | $356 | $14 |
| Hydrochlorothiazide | 27 | $240 | $9 |
| Meclizine | 17 | $210 | $12 |
| Naproxen | 29 | $193 | $7 |
| Triamterene-Hydrochlorothiazid | 15 | $183 | $12 |
| Fluoxetine | 17 | $177 | $10 |
| Carvedilol | 14 | $157 | $11 |
| Zolpidem | 28 | $143 | $5 |
| Fluconazole | 12 | $142 | $12 |
| Losartan | 12 | $142 | $12 |
| Glipizide | 16 | $128 | $8 |
| Atenolol | 16 | $127 | $8 |
| Metoprolol | 19 | $108 | $6 |
| Lorazepam | 13 | $61 | $5 |
| Furosemide | 12 | $59 | $5 |
| Tramadol | 12 | $55 | $5 |
| Baclofen | 14 | $53 | $4 |
2013: 5 drugs
| Proair Hfa | 13 | $834 | $64 |
| Gabapentin | 13 | $570 | $44 |
| Omeprazole | 14 | $336 | $24 |
| Amlodipine Besylate | 14 | $151 | $11 |
| Lisinopril | 16 | $147 | $9 |
Money from drug and device companies
$21 in 2023
| 2023 | 1 | 1 | None | $21 |
| 2019 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bayer Healthcare Pharmaceuticals | Mirena | $21 | 1 payment
|
See the published payment
| Bayer Healthcare Pharmaceuticals | Meals · 2023-05-31 | Mirena | $21 |
See earlier years (2019)
2019: $14
| TherapeuticsMD | Imvexxy | $14 | 1 payment
|
Professional record
- NPI
- 1780021766
- Licence
- CA A122988California A122988: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RA0401X (207RA0401X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2013-05-30
- NPI last updated
- 2025-01-30
- NPI record certified
- 2022-08-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3801 Sacramento St Ste 325, San Francisco, CA, 94118 · 899 Valencia St, San Francisco, CA, 94110